Document Detail


Biosimilars and regulatory authorities.
MedLine Citation:
PMID:  20689318     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
The patent expirations for many biotechnological medicines have prompted the development of copies of biological medicinal products. Unlike generics, biosimilars are similar but not identical to their reference product, because their chemical characteristics are directly related to the manufacturing process which cannot be precisely duplicated. The regulatory policy for biosimilars is complex and in Europe it is regulated mainly by guidelines issued by the European Medicines Agency (EMEA); additional product-class specific guidelines have been developed as in the case of recombinant human erythropoietin (rHuEPO). In 2008, the experience gained with this drug has prompted the development of a new guideline, currently in draft. In this review we critically discuss aspects related to EMEA guidelines, particularly focusing on rHuEPO.
Authors:
Paola Minghetti; Paolo Rocco; Lucia Del Vecchio; Francesco Locatelli
Related Documents :
18990328 - Management of syncope in adults: an update.
16363418 - A review of the updated european best practice guidelines for the management of anaemia...
4002118 - Successful management of late-onset primary lymphatic hypoplasia.
9343018 - Management of intersexuality. guidelines for dealing with persons with ambiguous genita...
12737268 - Dose and enantiospecific responses of white pine cone beetles, conophthorus coniperda, ...
11084388 - Successful implementation of automation in medicinal chemistry.
Publication Detail:
Type:  Journal Article     Date:  2010-08-03
Journal Detail:
Title:  Nephron. Clinical practice     Volume:  117     ISSN:  1660-2110     ISO Abbreviation:  Nephron Clin Pract     Publication Date:  2011  
Date Detail:
Created Date:  2011-01-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101159763     Medline TA:  Nephron Clin Pract     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  c1-7     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 S. Karger AG, Basel.
Affiliation:
Department of Pharmaceutical Sciences P. Pratesi, Università degli Studi di Milano, Milan, Italy. paola.minghetti@unimi.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Rotavirus genotypes in Costa Rica, Nicaragua, Honduras and the Dominican Republic.
Next Document:  Oral cyclophosphamide is on the verge of extinction as therapy for severe autoimmune diseases (espec...